Hormone Use in Menopause and Male Andropause
A Choice for Women and Men
- Publisher's listprice GBP 35.99
-
17 194 Ft (16 375 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 1 719 Ft off)
- Discounted price 15 474 Ft (14 738 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
17 194 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP Oxford
- Date of Publication 20 November 2003
- ISBN 9780195159745
- Binding Hardback
- No. of pages224 pages
- Size 160x246x19 mm
- Weight 467 g
- Language English 0
Categories
Short description:
This book, by two of the most distinguished figures in fertility and reproduction research, answers all the most common questions about menopause and andropause, and hormone resupplement therapy (HRT) for menopausal women. It offers explanations of all aspects of this subject, presenting balanced and reliable information about benefits, risks, and prospects for this field. The book also gives full and detailed treatment of the hormone- and age-related decline in male sexual vigour, the andropause. the book is unique in including coverage of the climacteric in men.
MoreLong description:
This book, by two of the most distinguished figures in fertility and reproduction research, answers all the most common questions about menopause and andropause, and hormone resupplement therapy (HRT) for menopausal women. It offers explanations of all aspects of this subject, presenting balanced and reliable information about benefits, risks, and prospects for this field. Segal invented Norplant, the first long-term implantable contraceptive, and as the leader of Reproductive Biology at the Population Council, he orchestrated and coordinated the research and trials leading to basically every new contraceptive introduced over a period of about 25 years. Mastroianni did more than anyone else to develop in vitro fertizilation as a viable treatment option, and was for many years the chairman of the largest department of obstetrics and gynecology, and the director of the most successful IVF clinic. This book is unique in including coverage of the climacteric in men.
MoreTable of Contents:
Part I: Menopause
Why do women have menopause?
What are the signs of menopause?
What is menopausal hormone therapy?
Why should women consider hormone therapy?
Risk-benefit ratio: Making the choice
Can HRT protect brain function and prevent Alzheimer's Disease?
Does the approach of menopause mean the end of fertility?
Herbal products for menopause
Can phytoestrogens, antioxidants and vitamins replace HT?
Sex and the aging woman
What is the status of designer estrogens?
Part II: Male Andropause
Is there a "male menopause"?
Is testosterone the only androgen the body produces?
Why should men consider androgen supplementation therapy?
What are the AST choices for men?
The first designer androgen for men
Can men safely use AST?
Should aging men use nonprescription androgens?
Sex and the aging man
Can AST help brain function in aging men?
Part III: Questions and Answers
Questions about menopause
Questions about andropause
